金吾财讯 | 生物科技股逆市有支撑，截至发稿，药捷安康-B(02617)涨31.01%，三叶草生物-B(02197)涨7.80%，康宁杰瑞制药-B(09966)涨6.57%，映恩生物-B(09606)涨5.69%，轩竹生物-B(02575)涨3.93%，基石药业-B(02616)涨3.78%，银诺医药-B(02591)涨2.77%，同源康医药-B(02410)涨2.55%，荃信生物-B(02509)涨2.60%。华福证券指出，即将召开的欧洲肿瘤内科学会（ESMO）年会上公布的中国创新药临床数据，预计会成为市场主要关注点，也建议关注三季度业绩报告的披露和11月的国家医保谈判。该行表示，中国创新药正在“量变引起质变”，看好创新药5-10年的产业趋势，BD出海、持续数据催化和新产品销售放量将依次推动创新药崛起。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.